28 related articles for article (PubMed ID: 6605525)
1. [Immunotherapy of chronic active hepatitis (HBsAg+) with calf thymus extract (TFX-Polfa). Evaluation of the efficiency of cellular mechanisms of the immunologic response].
Dabrowska-Bernstein BK; Dabrowski MP; Stasiak A; Wasowska B; Brzosko WJ
Pol Tyg Lek; 1984 Aug; 39(33):1091-6. PubMed ID: 6334280
[No Abstract] [Full Text] [Related]
2. [Clinical trial of treatment with the preparation TFX "Polfa" of 4 patients with acquired immunologic deficiency syndromes].
Romański B; Montowska L; Zbikowska-Götz M; Staszyńska M
Pol Tyg Lek; 1985 Oct 7-14; 40(40-41):1139-42. PubMed ID: 3911181
[No Abstract] [Full Text] [Related]
3. [Clinical effectiveness of T-activin in the treatment of cutaneous forms of lupus erythematosus].
Skripkin IuK; Biriukov AV; Stenina MA; Skripnik AIu; Korotkiĭ NG
Vestn Dermatol Venerol; 1985 May; (5):8-11. PubMed ID: 3898631
[No Abstract] [Full Text] [Related]
4. [Calf thymus extract (TFX-Polfa) in the treatment of pollinosis. Clinical trials by the double-blind method using a placebo].
Kowalski ML; Kuna P; Grzegorczyk J; Rozniecki J
Pol Tyg Lek; 1987 Jun; 42(24):739-42. PubMed ID: 3313315
[No Abstract] [Full Text] [Related]
5. [Immunotherapy of chronic active hepatitis (HBsAg+) with calf thymus extract (TFX-Polfa). Clinical evaluation].
Cianciara J; Babiuch L; Górska E; Kassur B
Pol Tyg Lek; 1984 Aug; 39(33):1097-101. PubMed ID: 6390376
[No Abstract] [Full Text] [Related]
6. [Therapeutic effectiveness of the immuno stimulating extract of the calf thymus (TFX-Polfa) in cases of acute dermatomyositis].
Stasiak A; Dudkiéwicz H; Dabrowski M; Dabrowska B; Wasowska B; Brzosko W
Pol Tyg Lek; 1983 Mar; 38(13):389-92. PubMed ID: 6605525
[No Abstract] [Full Text] [Related]
7. Therapeutic application of calf thymus extract (TFX).
Skotnicki AB
Med Oncol Tumor Pharmacother; 1989; 6(1):31-43. PubMed ID: 2657248
[TBL] [Abstract][Full Text] [Related]
8. Intravenous immunoglobulin therapy.
Stein LD; Roifman CM
Bull Rheum Dis; 1995 Jun; 44(4):3-5. PubMed ID: 7787963
[No Abstract] [Full Text] [Related]
9. [Photopheresis: new immunomodulatory therapy for T-lymphocite mediated diseases].
Vagace Valero JM; Alonso Escobar N; De Argila Fernández-Durán D; Vargas Pérez L; Melero Ruiz J; Morán Penco JM; Bajo Gómez R; Pérez Miranda M
An Med Interna; 2003 Aug; 20(8):421-6. PubMed ID: 14516265
[TBL] [Abstract][Full Text] [Related]
10. [Lung and autoimmune disease--therapy].
Hauber HP; Zabel P
Dtsch Med Wochenschr; 2007 Aug; 132(33):1703-6. PubMed ID: 17713868
[TBL] [Abstract][Full Text] [Related]
11. Intravenous immunoglobulin: an emerging treatment for immune-mediated skin diseases.
Rütter A; Luger TA
Curr Opin Investig Drugs; 2002 May; 3(5):713-9. PubMed ID: 12090544
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
